Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date | Reported DateTime | Exercisable Expiration | Company | Symnbol | Insider Relationship | Shares Traded | Conversion Price | Shares Owned | Filing |
| 2024-06-05 Option Award | 2024-06-07 4:30 pm | N/A 2034-06-04 | Syros Pharmaceuticals Inc. | SYRS | OH ANDREW M. Director | 10,000 | $0 | 22,000 (Direct) | View |
| 2023-06-01 Option Award | 2023-06-02 4:25 pm | N/A 2033-05-31 | Syros Pharmaceuticals Inc. | SYRS | OH ANDREW M. Director | 10,000 | $0 | 18,000 (Direct) | View |
| 2022-09-16 Option Award | 2022-09-19 5:14 pm | N/A 2032-09-15 | Syros Pharmaceuticals Inc. | SYRS | OH ANDREW M. Director | 20,000 | $0 | 20,000 (Direct) | View |
| 2020-05-15 Exercise | 2020-05-19 8:02 pm | N/A 2028-02-14 | Rubius Therapeutics Inc. | RUBY | OH ANDREW M. Chief Financial Officer | 5,000 | $0 | 760,500 (Direct) | View |
| 2020-05-15 Exercise | 2020-05-19 8:02 pm | N/A N/A | Rubius Therapeutics Inc. | RUBY | OH ANDREW M. Chief Financial Officer | 5,000 | $4.74 | 760,500 (Direct) | View |
| 2020-01-31 Option Award | 2020-02-03 9:48 pm | N/A 2030-01-30 | Rubius Therapeutics Inc. | RUBY | OH ANDREW M. Chief Financial Officer | 165,000 | $0 | 165,000 (Direct) | View |